McKesson (MCK) Tops Q3 EPS by 18c, Beats on Revenue; Offers FY26 EPS Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Jefferies says this healthcare stock is one of its top picks
February 6, 2026 6:30 PM ESTJefferies highlighted one of its top healthcare picks in a note to clients this week, citing strong fundamentals and execution that have driven margin and earnings growth.
Analyst Brian Tanquilut said the bullish stance on McKesson (NYSE: MCK) is largely driven by what we view as very compelling secular trends and growth outlook in the drug... More
